Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$1.4B |
| 2 |
ExxonMobil
XOM
|
+$1.39B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$932M |
| 4 |
Procter & Gamble
PG
|
+$925M |
| 5 |
Walmart Inc
WMT
|
+$834M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASML
ASML
|
+$1.66B |
| 2 |
Salesforce
CRM
|
+$1.17B |
| 3 |
Lam Research
LRCX
|
+$974M |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$972M |
| 5 |
Applied Materials
AMAT
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.72% |
| 2 | Financials | 12.27% |
| 3 | Healthcare | 10.07% |
| 4 | Consumer Discretionary | 9.98% |
| 5 | Industrials | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Lantheus
LNTH
$6.59B
| $9.86M | ﹤0.01% |
158,375
-129
| -0.1% | -$7.59K |
|
|
PCH
427
DELISTED
PotlatchDeltic
PCH
| $9.76M | ﹤0.01% |
207,546
+3,558
| +2% | +$164K |
|
428
Denali Therapeutics
DNLI
$3.97B
| $9.63M | ﹤0.01% |
+469,169
| New | +$8.82M |
|
429
Steel Dynamics
STLD
$37.6B
| $9.6M | ﹤0.01% |
64,779
+3,946
| +6% | +$496K |
|
430
Associated Banc-Corp
ASB
$5.91B
| $9.55M | ﹤0.01% |
444,024
-38,976
| -8% | -$814K |
|
431
Invesco NASDAQ 100 ETF
QQQM
$102B
| $9.51M | ﹤0.01% |
52,076
-20,081
| -28% | -$3.54M |
|
432
Global Payments
GPN
$22.8B
| $9.5M | ﹤0.01% |
71,059
+737
| +1% | +$97.4K |
|
|
SWN
433
DELISTED
Southwestern Energy Company
SWN
| $9.42M | ﹤0.01% |
1,243,361
+11,193
| +0.9% | +$76K |
|
434
Seacoast Banking Corp of Florida
SBCF
$3.35B
| $9.28M | ﹤0.01% |
365,350
-163,944
| -31% | -$4.13M |
|
435
Trex
TREX
$5.01B
| $9.23M | ﹤0.01% |
92,507
-6,213
| -6% | -$553K |
|
436
Bankunited
BKU
$3.36B
| $9.21M | ﹤0.01% |
+329,000
| New | +$9.2M |
|
437
Neurocrine Biosciences
NBIX
$16.6B
| $8.99M | ﹤0.01% |
65,166
+4,939
| +8% | +$675K |
|
438
Renasant Corp
RNST
$3.91B
| $8.87M | ﹤0.01% |
283,351
-29,000
| -9% | -$909K |
|
439
Viavi Solutions
VIAV
$9.66B
| $8.79M | ﹤0.01% |
967,339
+31,497
| +3% | +$309K |
|
440
Essential Properties Realty Trust
EPRT
$6.62B
| $8.72M | ﹤0.01% |
327,000
-34,063
| -9% | -$854K |
|
441
McDonald's
MCD
$195B
| $8.7M | ﹤0.01% |
30,850
+1,069
| +4% | +$311K |
|
442
Pebblebrook Hotel Trust
PEB
$2.05B
| $8.36M | ﹤0.01% |
542,623
-1,452
| -0.3% | -$22.9K |
|
443
EOG Resources
EOG
$70.7B
| $8.33M | ﹤0.01% |
65,147
+38,684
| +146% | +$4.52M |
|
444
General Mills
GIS
$19.7B
| $8.31M | ﹤0.01% |
118,819
+7,586
| +7% | +$494K |
|
445
Myriad Genetics
MYGN
$312M
| $8.28M | ﹤0.01% |
388,347
+230,378
| +146% | +$4.95M |
|
446
WSFS Financial
WSFS
$4.15B
| $8.26M | ﹤0.01% |
183,052
+50,000
| +38% | +$2.18M |
|
447
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.74B
| $8.16M | ﹤0.01% |
98,927
-8,134
| -8% | -$644K |
|
|
PPBI
448
DELISTED
Pacific Premier Bancorp
PPBI
| $8.11M | ﹤0.01% |
338,000
+113,000
| +50% | +$2.83M |
|
|
SAGE
449
DELISTED
Sage Therapeutics
SAGE
| $8.1M | ﹤0.01% |
432,469
+544
| +0.1% | +$12.5K |
|
450
Vericel Corp
VCEL
$2.31B
| $8.02M | ﹤0.01% |
154,167
-3,013
| -2% | -$132K |
|
Similar funds
Ken Fisher's Q1 2024 Portfolio in Review
As of Q1 2024, Ken Fisher held 1,068 positions worth $214B, up 13% from $189B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Fisher's Q1 2024 filing shows 87 new, 392 increased, 448 reduced and 104 closed positions. Its largest new stake was Nomura Holdings: 8,478,338 shares worth $54.4M. The largest sale was ASML, an estimated $1.66B.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.
- Ken Fisher's largest Q1 2024 buy was Nomura Holdings: 8,478,338 shares worth $54.4M.
- Ken Fisher added most to Chevron in Q1 2024, an estimated $1.4B increase.
- Ken Fisher's biggest Q1 2024 reduction was ASML, cutting an estimated $1.66B.
- Ken Fisher fully exited Veradigm Inc. Common Stock in Q1 2024, selling an estimated $23.8M.
- Ken Fisher's ten largest holdings make up 31% of its $214B portfolio in Q1 2024.
- Ken Fisher opened 87 new positions and closed 104 in Q1 2024.
- Ken Fisher's portfolio value rose 13% quarter-over-quarter to $214B.
Based on Fisher Asset Management's 13F filing for Q1 2024, filed 9 May 2024.